Menu
Expand Search

2010-2019

2019 ADR

Due to unforeseen administrative issues, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has decided that the 2019 edition of the USRDS Annual Data Report (ADR) will be abbreviated. The 2019 ADR, produced by the University of Michigan contractors, consists of a summary chapter and a shortened number of data tables that capture the essential information the renal community has come to expect. The Transition of Care chapter was produced by the USRDS Special Study Center on Transition of Care in chronic kidney disease (CKD). NIDDK expects that a full ADR will be published in 2020. Quarterly updates on the website will be available before the full ADR is published.

Executive Summary: Overview of Kidney Disease in the United States

2019 Executive Summary

Transition of Care

Transition of Care in Chronic Kidney Disease

Suggested USRDS citation for this report:
United States Renal Data System. 2019 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2019.

Publications based upon USRDS data must include this citation and the following notice:
The data reported here have been supplied by the United States Renal Data System (USRDS). The interpretation and reporting of these data are the responsibility of the author(s) and in no way should be seen as an official policy or interpretation of the U.S. Government.

The suggested citation for the AJKD e-supplement is:
Saran R, Robinson B, Abbott KC, et al. US Renal Data System 2019 Annual Data Report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2020;75(1)(suppl 1):Svi-Svii.

Reference Tables

Due to unforeseen administrative issues, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has decided that the 2019 edition of the USRDS Annual Data Report (ADR) will be abbreviated. The 2019 ADR, produced by the University of Michigan contractors, consists of a summary chapter and a shortened number of data tables that will capture the essential information the renal community has come to expect. NIDDK expects that a full ADR will be published in 2020. Quarterly updates on the website will be available before the full ADR is published.

The 2019 USRDS Annual Data Report Reference Tables are available as MS Excel files. To view, you may click on the title of each section or download all the sections to your computer.
Contact us for information to order the ADR on DVD. Forms are in Adobe Acrobat™ PDF

Reference Tables

Volume 2 - End-stage Renal Disease (ESRD)

A. Incidence
B. Prevalence
C. Patient Characteristics
D. Treatment Modalities
E. Transplantation: Process
F. Transplantation Outcomes
G. Morbidity and Hospitalization
H. Mortality and causes of Death
I. Patient Survival
J. Provider Characteristics
K. Cost
L. Vascular Access
M. Census Populations

2018 ADR CHAPTERS

The 2018 Annual Data Report is available in two volumes : Volume 1: Chronic Kidney Disease in the United States and Volume 2: End-Stage Renal Disease in the United States. Both sections of the ADR focus on a visual display of information through graphs and maps. In the HTML version, all figures are linked to a pop-up window.

Acknowledgments

Executive Summary:Overview of Kidney Disease in the United States

Executive Summary       

Chronic Kidney Disease (CKD) in the United States  (Download Full Volume)

Chapter
1. CKD in the General Population     
2. Identification and Care of Patients with CKD     
3. Morbidity & Mortality in Patients With CKD     
4. Cardiovascular Disease in Patients with CKD     
5. Acute Kidney Injury      
6. CKD among Children and Adolescents    
7. Healthcare Expenditures for Persons with CKD      
8. Prescription Drug Coverage in Patients with CKD     
9. Special Study - Transition of Care in Chronic Kidney Disease     
CKD Analytical Methods       

End-stage Renal Disease (ESRD) in the United States (Download Full Volume)

Chapter
1. Incidence, Prevalence, Patient Characteristics, and Treatment Modalities.       
2. Clinical Indicators & Preventive Care         
3. Vascular Access        
4. Hospitalization        
5. Mortality        
6. Transplantation        
7. ESRD among Children, Adolescents, and Young Adults        
8. Cardiovascular Disease in Patients With ESRD        
9. Healthcare Expenditures for Persons with ESRD        
10. Prescription Drug Coverage in Patients with ESRD        
11. International Comparisons        
12. End-of-life Care for Patients with End-Stage Rena Disease: 2000-2015        
ESRD Analytical Methods        

Healthy People 2020
  Healthy People 2020        

Reference Tables

Volume 1 - CKD:

B. Prevalence
K. Expenditures 

Volume 2 - ESRD:

A. Incidence
B. Prevalence
C. Patients Characteristics
D. Treatment Modalities
E. Transplantation: Process
F: Transplantation: Outcomes
G. Morbidity and Hospitalization
H. Mortality and Causes of Death
I. Patient Survival
J. Provider Characteristics
K. Expenditures for ESRD patients
L. Vascular Access
M. Census Populations
N. International Comparisons

Appendices (Download all appendices)

1. Glossary & Abbreviations
   1.1 . Glossary
   1.2 . Abbreviations
2.  USRDS Data Use Agreement Forms (revised 08/08/2016)
   2.1 . Agreement for Release of Data
   2.2 . Merged Dataset Agreement for Release of Data
3. CMS Forms
4. USRDS International Data Collection Form

Suggested USRDS citation for this report:
United States Renal Data System. 2018 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2018.

Publications based upon USRDS data must include this citation and the following notice:
The data reported here have been supplied by the United States Renal Data System (USRDS). The interpretation and reporting of these data are the responsibility of the author(s) and in no way should be seen as an official policy or interpretation of the U.S. Government.

The suggested citation for the AJKD e-supplement is:
Saran R, Robinson B, Abbott KC, et al. US Renal Data System. 2018 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. Am J Kidney Dis. 2019;73(3)(suppl 1):Svii-Sxxii, S1-S772.

2017 ADR CHAPTERS

The 2017 Annual Data Report is available in two volumes : Volume 1: Chronic Kidney Disease in the United States and Volume 2: End-Stage Renal Disease in the United States. Both sections of the ADR focus on a visual display of information through graphs and maps. In the HTML version, all figures are linked to a pop-up window. 

Acknowledgments

Executive Summary:Overview of Kidney Disease in the United States

Executive Summary       

Chronic Kidney Disease (CKD) in the United States  (Download Full Volume)

Chapter
1. CKD in the General Population       
2. Identification and Care of Patients with CKD      
3. Morbidity & Mortality in Patients With CKD        
4. Cardiovascular Disease in Patients with CKD       
5. Acute Kidney Injury      
6. Healthcare Expenditures for Persons with CKD        
7. Prescription Drug Coverage in Patients With CKD    
8. Transition of Care in Chronic Kidney Disease CKD     
CKD Analytical Methods:        

End-stage Renal Disease (ESRD) in the United States (Download Full Volume)

Chapter
1. Incidence, Prevalence, Patient Characteristics, and Treatment Modalities.       
2. Clinical Indicators & Preventive Care         
3. Vascular Access        
4. Hospitalization        
5. Mortality        
6. Transplantation        
7. ESRD among Children, Adolescents, and Young Adults      
8. Cardiovascular Disease in Patients With ESRD        
9. Healthcare Expenditures for Persons with ESRD        
10. Prescription Drug Coverage in Patients with ESRD        
11. International Comparisons        
12. End-of-life Care for Patients with End-Stage Rena Disease: 2000-2014        
ESRD Analytical Methods: ESRD        

Healthy People 2020
  Healthy People 2020     

Reference Tables

Volume 1 - CKD:

B. Prevalence
K. Economic Costs of CKD

Volume 2 - ESRD:

A. Incidence
B. Prevalence
C. Patients Characteristics
D. Treatment Modalities
E. Transplantation: Process
F: Transplantation: Outcomes
G. Morbidity and Hospitalization
H. Mortality and Causes of Death
I. Patient Survival
J. Provider Characteristics
K. Economic Costs for ESRD
L. Vascular Access
M. Census Populations
N. International Comparisons

Appendices (Download all appendices)

1. Glossary & Abbreviations
   1.1 . Glossary
   1.2 . Abbreviations
2.  USRDS Data Use Agreement Forms
   2.1 . Agreement for Release of Data
   2.2 . Merged Dataset Agreement for Release of Data
3. CMS Forms
  3.1 . FORM CMS-2728-U3 (08/15)
  3.2. FORM CMS-2728-U3 (06/04) EF(03/2005)
4. USRDS International Data Collection Form


Suggested USRDS citation for this report:
United States Renal Data System. 2017 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2017.

Publications based upon USRDS data must include this citation and the following notice:
The data reported here have been supplied by the United States Renal Data System (USRDS). The interpretation and reporting of these data are the responsibility of the author(s) and in no way should be seen as an official policy or interpretation of the U.S. Government.

The suggested citation for the AJKD e-supplement is:
Saran R, Robinson B, Abbott KC, et al. US Renal Data System. 2017 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. Am J Kidney Dis. 2018;71(3)(suppl 1):Svii,S1-S672.

2016 ADR CHAPTERS

The 2016 Annual Data Report is available in two volumes : Volume 1: Chronic Kidney Disease in the United States and Volume 2: End-Stage Renal Disease in the United States. Both sections of the ADR focus on a visual display of information through graphs and maps. In the HTML version, all figures are linked to a pop-up window. 

Acknowledgments

Volume 1 - Chronic Kidney Disease (CKD) in the United States (Download Full Volume)

Introduction    
1. CKD in the General Population       
2. Identification and Care of Patients with CKD      
3. Morbidity & Mortality in Patients With CKD     
4. Cardiovascular Disease in Patients with CKD    
5. Acute Kidney Injury    
6. Medicare Expenditures for Persons With CKD     
7. Medicare Part D Prescription Drug Coverage in Patients With CKD     
8. USRDS Special Study Center on Transition of Care in CKD       
CKD Analytical Methods:        

Volume 2 - End-stage Renal Disease (ESRD) in the United States (Download Full Volume)

Introduction     
1. Incidence, Prevalence, Patient Characteristics, and Treatment Modalities.    
2. Healthy People 2020     
3. Clinical Indicators & Preventive Care     
4. Vascular Access     
5. Hospitalization     
6. Mortality     
7. Transplantation     
8. Pediatric ESRD      
9. Cardiovascular Disease in Patients With ESRD     
10. Dialysis Providers     
11. Medicare Expenditures for Persons With ESRD    
12. Medicare Part D Prescription Drug Coverage in Patients with ESRD    
13. International Comparisons   
14. USRDS Special Study Center on End-of-Life Care for Patients With ESRD    
ESRD Analytical Methods: ESRD         

Reference Tables

Volume 1 - CKD
  All CKD Tables

Volume 2 - ESRD:

A. Incidence
B. Prevalence
C. Patients Characteristics
D. Treatment Modalities
E. Transplantation: Process
F: Transplantation: Outcomes
G. Morbidity and Hospitalization
H. Mortality and Causes of Death
I. Patient Survival
J. Provider Characteristics
K. Economic Costs for ESRD
L. Vascular Access
M. Census Populations
N. International Comparisons

Appendices (Download all appendices)

1. Glossary & Abbreviations
   1.1 . Glossary
   1.2 . Abbreviations
2.  USRDS Data Use Agreement Forms (revised 08/08/2016)
   2.1 . Agreement for Release of Data
   2.2 . Merged Dataset Agreement for Release of Data
3. CMS Forms
4. USRDS International Data Collection Form 

Suggested USRDS citation for this report:
United States Renal Data System. 2016 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2016.

Publications based upon USRDS data must include this citation and the following notice:
The data reported here have been supplied by the United States Renal Data System (USRDS). The interpretation and reporting of these data are the responsibility of the author(s) and in no way should be seen as an official policy or interpretation of the U.S. Government.

The suggested citation for the forthcoming AJKD e-supplement is:
Saran R, Robinson B, Abbott KC, et al. US Renal Data System. 2016 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. Am J Kidney Dis 2017;69(3)(suppl 1):S1-S688.

2015 ADR CHAPTERS

The 2015 Annual Data Report is available in two volumes : Volume 1: Chronic Kidney Disease in the United States and Volume 2: End-Stage Renal Disease in the United States. Both sections of the ADR focus on a visual display of information through graphs and maps. In the HTML version, all figures are linked to a pop-up window. 

Acknowledgments

Volume 1 - Chronic Kidney Disease (CKD) in the United States (Download Full Volume)

Introduction   
1. CKD in the General Population   
2. Identification and Care of Patients with CKD   
3.  Morbidity & Mortality in Patients With CKD    
4. Cardiovascular Disease in Patients with CKD   
5. Acute Kidney Injury    
6. Medicare Expenditures for Persons With CKD    
7. Medicare Part D Prescription Drug Coverage in Patients With CKD    
8. USRDS Special Study Center on Transition of Care in CKD   
CKD Analytical Methods       

Volume 2 - End-stage Renal Disease (ESRD) in the United States (Download Full Volume)

Introduction   
1. Incidence, Prevalence, Patient Characteristics, and Treatment Modalities.   
2. Healthy People 2020    
3. Clinical Indicators & Preventive Care    
4. Vascular Access    
5. Hospitalization    
6. Mortality    
7. Transplantation    
8. Pediatric ESRD     
9. Cardiovascular Disease in Patients With ESRD  Updated - 09/19/2016   
10. Dialysis Providers    
11. Medicare Expenditures for Persons With ESRD   
12. Medicare Part D Prescription Drug Coverage in Patients with ESRD   
13. International Comparisons    
14. USRDS Special Study Center on End-of-Life Care for Patients With ESRD    
ESRD Analytical Methods: ESRD        

Reference Tables

Volume 1 - CKD
  All CKD Tables

Volume 2 - ESRD:

A. Incidence
B. Prevalence
C. Patients Characteristics
D. Treatment Modalities
E. Transplantation: Process
F: Transplantation: Outcomes
G. Morbidity and Hospitalization
H. Mortality and Causes of Death
I. Patient Survival
J. Provider Characteristics
K. Economic Costs for ESRD
L. Vascular Access
M. Census Populations

Appendices / Products & Services (Download all appendices)

1. Glossary & Abbreviations
   1.1 . Glossary
   1.2 . Abbreviations
2. Products & Services
3. USRDS Data Use Agreement Forms (revised 03/09/2016)
   3.1 . Agreement for Release of Data
   3.2 . Merged Dataset Agreement for Release of Data
4. CMS Forms
5. USRDS International Data Collection Form

Suggested USRDS citation for this report:
United States Renal Data System. 2015 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2015.

Publications based upon USRDS data must include this citation and the following notice:
The data reported here have been supplied by the United States Renal Data System (USRDS). The interpretation and reporting of these data are the responsibility of the author(s) and in no way should be seen as an official policy or interpretation of the U.S. Government.

The suggested citation for the AJKD e-supplement available at www.ajkd.org is as follows:
Saran R, Li Y, Robinson B, et al. United States Renal Data System. 2015 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. Am J Kidney Dis 2016;67(3)(suppl 1):S1-S434.

2014 ADR CHAPTERS

The 2014 Annual Data Report is divided into two volumes this year, Volume One: Chronic Kidney Disease in the United States and Volume Two: End-Stage Renal Disease in the United States. Both sections of the ADR focus on a visual display of information through graphs and maps. In the HTML version, all figures are linked to a pop-up window. 

Acknowledgments

Volume 1 - Atlas CKD (Download Full Volume)

Introduction    
1. CKD in the General Population   
2. Identification and Care of Patients with CKD   
3.  Morbidity & Mortality   
4. Cardiovascular Disease in Patients with CKD  
5. Acute Kidney Injury  
6. Medicare Expenditures for CKD   
Analytical Methods: CKD        

Volume 2 - End-stage Renal Disease (ESRD) in the United States (Download Full Volume)

Introduction  
1. Incidence, Prevalence, Patient Characteristics, and Treatment Modalities.  
2. Healthy People 2020   
3. Clinical Indicators & Preventive Care 
4. Hospitalization 
5. Mortality 
6. Transplantation  
7. Pediatric ESRD  
8. Dialysis Providers  
9. Cost of ESRD 
10. International Comparisons   
11. USRDS Special Study Center on Palliative and End-of-Life Care  
12. USRDS Special Study Center on Transition of Care in CKD     
ESRD Analytical Methods: ESRD          

ADR 2014 - Reference Tables (Download Full Volume)

Volume 1 - CKD
All CKD Tables

Volume 2 - ESRD:

A. Incidence
B. Prevalence
C. Patients Characteristics
D. Treatment Modalities
E. Transplantation: Process
F: Transplantation: Outcomes
G. Morbidity and Hospitalization
H. Mortality and Causes of Death
I. Patient Survival
J. Provider Characteristics
K. Economic Costs for ESRD (Not available)
L. Vascular Access
M. Census Populations

Suggested citation for this report:
United States Renal Data System. 2014 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2014.

Publications based upon USRDS data reported here or supplied upon request must include this citation and the following notice:
The data reported here have been supplied by the United States Renal Data System (USRDS). The interpretation and reporting of these data are the responsibility of the author(s) and in no way should be seen as an official policy or interpretation of the U.S. Government.

2013 Atlas of CKD & ESRD

This year's Annual Data Report features more extensive analyses of the Part D prescription drug plans, rehospitalization rates, and cardiovascular disease in the CKD and ESRD populations. Click on a title to view a PDF of each chapter. PDFs, MS Excel files, and PowerPoint slides can be downloaded by choosing the appropriate icon to the right of each chapter. 

Volume 1 - Atlas CKD (Download Full Volume)

Introduction        
Precis  
1. CKD in the General Population  
2. Identification and Care of Patients with CKD  
3.  Morbidity & Mortality  
4. Cardiovascular Disease in Patients with CKD 
5. Prescription Drug Coverage 
6. Acute Kidney Injury  
7. Cost of CKD  
Reference Tables: CKD    
Analytical Methods: CKD       

Volume 2 - Atlas ESRD (Download Full Volume)

An Introduction to ESRD in the U.S.       
Precis 
HP2020  Healthy People 2020 
1. Incidence, Prevalence, Patient Characteristics, and Modalities. 
2. Clinical Indicators & Preventive Care 

3. Hospitalization 
4. Cardiovascular Disease 
5. Mortality  
6. Prescription Drug Coverage
7. Transplantation 
8. Pediatric ESRD  
9. Special Studies        
10. Providers (Introduction updated 9/27/2012)   
11. Cost of ESRD  
12. International Comparisons 
Condensed Reference Tales: ESRD           
Analytical Methods: ESRD         
Products & Services      

ADR 2013 - Reference Tables (Download Full Volume)

A. Incidence
B. Prevalence
C. Patients Characteristics
D. Treatment Modalities
E. Transplantation: Process
F: Transplantation: Outcomes
G. Morbidity and Hospitalization
H. Mortality and Causes of Death
I. Patient Survival
J. Provider Characteristics
K. Economic Costs for ESRD
L. Vascular Access
M. Census Populations

Suggested citation for this report:
United States Renal Data System. 2013 USRDS Annual Data Report: Atlas of chronic kidney disease and end-stage renal disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2013.

Publications based upon USRDS data reported here or supplied upon request must include this citation and the following notice:
The data reported here have been supplied by the United States Renal Data System (USRDS). The interpretation and reporting of these data are the responsibility of the author(s) and in no way should be seen as an official policy or interpretation of the U.S. Government.

Citations should separate chapter, number, and volume by periods — i.e., 3.1.ii refers to Chapter Three, Figure 1, Volume Two.

2012 Atlas of CKD & ESRD

This year's Annual Data Report features more extensive analyses of the Part D prescription drug plans, rehospitalization rates, and cardiovascular disease in the CKD and ESRD populations. Click on a title to view a PDF of each chapter. PDFs, MS Excel files, and PowerPoint slides can be downloaded by choosing the appropriate icon to the right of each chapter. 

Volume 1 - Atlas CKD (Download Full Volume)

Introduction            
Precis       Excel
1. CKD in the General Population      Excel
2. Identification and Care of Patients with CKD     Excel
3.  Morbidity & Mortality      Excel
4. Cardiovascular Disease in Patients with CKD      Excel
5. Prescription Drug Coverage      Excel
6. Acute Kidney Injury      Excel
7. Cost of CKD      Excel
Reference Tables: CKD    Excel  
Analytical Methods: CKD       

Volume 2 - Atlas ESRD (Download Full Volume)

An Introduction to ESRD in the U.S.       
Precis       Excel
HP2020  Healthy People 2020      Excel
1. Incidence, Prevalence, Patient Characteristics, and Modalities.      Excel
2. Clinical Indicators & Preventive Care       Excel
3. Hospitalization       Excel
4. Cardiovascular Disease       Excel
5. Mortality       Excel
6. Prescription Drug Coverage       Excel
7. Transplantation       Excel
8. Pediatric ESRD       Excel
9. Special Studies     Excel  
10. Providers (Introduction updated 9/27/2012)      Excel
11. Cost of ESRD       Excel
12. International Comparisons       Excel
Condensed Reference Tales: ESRD           
Analytical Methods: ESRD         

ADR 2012 - Reference Tables (Download Full Volume)

A. Incidence
B. Prevalence
C. Patients Characteristics
D. Treatment Modalities
E. Transplantation: Process
F: Transplantation: Outcomes
G. Morbidity and Hospitalization
H. Mortality and Causes of Death
I. Patient Survival
J. Provider Characteristics
K. Economic Costs for ESRD
L. Vascular Access
M. Census Populations

Suggested citation for this report:
United States Renal Data System. 2012 USRDS Annual Data Report: Atlas of chronic kidney disease and end-stage renal disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2012.

Publications based upon USRDS data reported here or supplied upon request must include this citation and the following notice:
The data reported here have been supplied by the United States Renal Data System (USRDS). The interpretation and reporting of these data are the responsibility of the author(s) and in no way should be seen as an official policy or interpretation of the U.S. Government.

Citations should separate chapter, number, and volume by periods — i.e., 3.1.ii refers to Chapter Three, Figure 1, Volume Two.

In titles, the superscript number or letter refers to the chapter, the following number or letter identifies the figure or table, and the italicized roman numeral identifies the volume. Citations should separate chapter, number, and volume by periods — i.e., 3.1.ii refers to Chapter Three, Figure 1, Volume Two.

2011 Atlas of CKD & ESRD

This year's Annual Data Report features more extensive analyses of the Part D prescription drug plans, rehospitalization rates, and cardiovascular disease in the CKD and ESRD populations. Click on a title to view a PDF of each chapter. PDFs, MS Excel files, and PowerPoint slides can be downloaded by choosing the appropriate icon to the right of each chapter. 

Volume 1 - Atlas CKD (Download Full Volume)

Introduction          
Precis    Excel
1. CKD in the General Population    Excel
2. Identification and Care of Patients with CKD     Excel
3. Morbidity & Mortality       Excel
4. Cardiovascular Disease in Patients with CKD       Excel
5. Prescription Drug Coverage      Excel
6. Cost of CKD       Excel
Reference Tables: CKD    Excel   
Analytical Methods: CKD      

Volume 2 - Atlas ESRD (Download Full Volume)

An Introduction to ESRD in the U.S.      
Precis        Excel
HP2020  Healthy People 2020   Excel
1. Incidence, Prevalence, Patient Characteristics, and Modalities.   Excel
2. Clinical Indicators & Preventive Care     Excel
3. Hospitalization      Excel
4. Cardiovascular Disease      Excel
5. Mortality     Excel
6. Prescription Drug Coverage      Excel
7. Transplantation      Excel
8. Pediatric ESRD     Excel
9. Special Studies       
10. Providers  Excel
11. Cost of ESRD   Excel
12. International Comparisons    Excel
Analytical Methods: ESRD        

ADR 2011 - Reference Tables (Download Full Volume)

A. Incidence
B. Prevalence
C. Patients Characteristics
D. Treatment Modalities
E. Transplantation: Process
F: Transplantation: Outcomes
G. Morbidity and Hospitalization
H. Mortality and Causes of Death
I. Patient Survival
J. Provider Characteristics
K. Economic Costs for ESRD
L. Vascular Access
M. Census Populations

Suggested citation for this report:
United States Renal Data System. 2011 USRDS Annual Data Report: Atlas of chronic kidney disease and end-stage renal disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2011.

Publications based upon USRDS data reported here or supplied upon request must include this citation and the following notice:
The data reported here have been supplied by the United States Renal Data System (USRDS). The interpretation and reporting of these data are the responsibility of the author(s) and in no way should be seen as an official policy or interpretation of the U.S. Government.

In titles, the superscript number or letter refers to the chapter, the following number or letter identifies the figure or table, and the italicized roman numeral identifies the volume. Citations should separate chapter, number, and volume by periods — i.e., 3.1.ii refers to Chapter Three, Figure 1, Volume Two.

2010 Atlas of CKD & ESRD

The 2010 ADR Atlas is divided into two volumes this year. Volume One: Atlas of Chronic Kidney Disease in the United States and Volume Two: Atlas of End-Stage Renal Disease in the United States. Both sections of the atlas, focuses on a visual display of information through graphs and maps. You can view and download both PDF files of these chapters and Excel files of the data underlying the figures. The downloadable files containing the chapters of the ADR are in Adobe Acrobat™, you will need the reader that will allow you to look at the documents. Slides are also available as PowerPoint & Excel files for downloading.

ADR 2010 - Volume One  (Download Full Volume 1)

Introduction  
Precis    Excel
1. CKD in the General Population    Excel
2. CKD Identified in the claims Data    Excel
3. Care of Patients with CKD    Excel
4. Morbidity & Mortality    Excel
5. Cardiovascular Disease in Patients with CKD    Excel
6. Outcomes in the Transition Zone in Nursing Home Patient with CKD    Excel
7. Transition to ESRD    Excel
8. Acute Kidney Injury    Excel
9. Cost of Chronic Kidney Disease    Excel
10. Reference Table    
Appendices       

ADR 2010 - Volume Two (Download Full Volume)

Introduction      
Precis    Excel
Healthy People 2010   Excel
1. Emerging Issues   Excel
2. Incidence & Prevalence of ESRD    Excel
3. Patient Characteristics   Excel
4. Treatment Modalities   
 Excel
5. Clinical Indicators & Preventive Health    Excel
6. Morbidity & Mortality    Excel
7. Transplantation    Excel
8. Pediatric ESRD    Excel
9. Special Studies    Excel
10. Providers    Excel
11. Cost of ESRD   Excel
12. International Comparisons   Excel
13. Reference Tables      
Appendices      


ADR 2010 - Reference Tables (Download Full Volume)

A. Incidence
B. Prevalence
C. Patients Characteristics
D. Treatment Modalities
E. Transplantation: Process
F: Transplantation: Outcomes
G. Morbidity and Hospitalization
H. Mortality and Causes of Death
I. Patient Survival
J. Provider Characteristics
K. Economic Costs for ESRD
L. Vascular Access
M. Census Populations

ADR 2010

Suggested citation for this report:
United States Renal Data System. 2010 USRDS Annual Data Report: Atlas of chronic kidney disease and end-stage renal disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2010.

Publications based upon USRDS data reported here or supplied upon request must include this citation and the following notice:
The data reported here have been supplied by the United States Renal Data System (USRDS). The interpretation and reporting of these data are the responsibility of the author(s) and in no way should be seen as an official policy or interpretation of the U.S. Government.

In titles, the superscript number or letter refers to the chapter, the following number or letter identifies the figure or table, and the italicized roman numeral identifies the volume. Citations should separate chapter, number, and volume by periods — i.e., 3.1.ii refers to Chapter Three, Figure 1, Volume Two.

USRDS Coordinating Center (CC)

Tel: 1.888.99USRDS
      (1.888.998.7737)

Email: usrds@usrds.org